Till the end of 2016, our department has treated?1097 patients of stroke (including cerebral hemorrhage and cerebral thrombosis) sequela. Among these patients, the longest onset time is 19 years, and the shortest is one month (only few patients). At present, our department is trying to apply stem cell transplantation to treat cerebrovasucular disease sequela in acute stage and recovery stage. The animal experiments confirmed that using stem cell transplantation in acute stage and recovery stage can save a large amount of nerve cells around the cerebral injured area (ischemic penumbra), and restore their neurological function, hence reduce the disability rate and handicapped degree. Once the patient passed recovery stage and get into sequela stage, the best treating time is gone, and nerve cells around ischemic penumbra start dying, then some hard and dense glial scars which obstruct nerve regeneration will be formed around the injured area. It will be much more difficult to treat the disease then. The improvement rate of stroke (including cerebral hemorrhage and cerebral thrombosis) sequela is 88%. Many patients have a certain degree of improvement even when they were in hospital, and the improvement shows on:
● Lower muscular tension
● Increase of muscle force
● Better sensation of body
● Better blood circulation of distal limbs
● Better motor function and fexibilities
● Better pronunciation and facial expression

 

Australian
58 years old

China
65 years old

China
58 years old

Pakistan
59 years old

About Us

The Stem Cell Department of General hospital of Chinese People’s Armed Police Forces is the first neural stem cell transplantation centre in China, which went through the World Health Organisation (WHO) clinical trial registration. The Hospital has also obtained the FDA clinical trial approval and had our laboratory certified with Good Manufacturing Procedures (GMP) certification of stem cell research and preparation. So far we have used stem cell therapy to treat 16,000+ patients from more than 30 countries.

Why choose us

Our department is the first nerve stem cell transplantation center in the country and abroad, which has passed through the WHO clinical registration test, received FDA approval of a clinical trial and was certified by the laboratory with the GMP standard of research. So far, we have already treated about 16,000+ patients from more than 30 countries with stem cell transplantation.

Contact us

Address: YongDing Road 69#, Haidian District, Beijing

Telephoe: +86 10 56259395

E-mail: [email protected]

Connect with us

Invalid Input

Invalid Input

Invalid Input